GUGLIELMINI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 806
EU - Europa 562
AS - Asia 309
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.682
Nazione #
US - Stati Uniti d'America 805
IE - Irlanda 162
IT - Italia 131
HK - Hong Kong 122
SG - Singapore 90
UA - Ucraina 67
CN - Cina 55
DE - Germania 53
SE - Svezia 52
FI - Finlandia 28
RU - Federazione Russa 23
VN - Vietnam 19
GB - Regno Unito 14
KR - Corea 9
MK - Macedonia 8
TR - Turchia 8
FR - Francia 6
BE - Belgio 4
GR - Grecia 3
NL - Olanda 3
AT - Austria 2
AU - Australia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
BG - Bulgaria 1
CA - Canada 1
EU - Europa 1
IN - India 1
IR - Iran 1
JP - Giappone 1
PH - Filippine 1
PL - Polonia 1
Totale 1.682
Città #
Chandler 210
Dublin 160
Hong Kong 122
San Mateo 82
Singapore 68
Boardman 48
Santa Clara 44
Perugia 43
Altamura 40
Jacksonville 40
Lawrence 33
Medford 33
Princeton 33
Ann Arbor 32
Beijing 20
Dong Ket 19
Wilmington 16
Andover 14
Dearborn 12
Redmond 12
Saint Petersburg 11
Seoul 9
Izmir 8
San Paolo di Civitate 8
Munich 7
Dallas 6
Des Moines 6
Nürnberg 6
San Diego 6
Woodbridge 6
Norwalk 5
Brussels 4
Falls Church 4
Helsinki 4
Los Angeles 4
New York 4
Florence 3
Skopje 3
Amelia 2
Bardovci 2
Den Haag 2
Espoo 2
Falkenstein 2
Genoa 2
Johannesburg 2
Lappeenranta 2
Newton Stewart 2
Padova 2
Pescara 2
Rome 2
Trento 2
Agrigento 1
Ashburn 1
Bastia 1
Bruckmühl 1
Castelnuovo Rangone 1
Chicago 1
Frankfurt Am Main 1
Fuzhou 1
Houston 1
Kakinada 1
Kicevo 1
Leawood 1
Logan 1
Ludwigshafen am Rhein 1
Moscow 1
Nanjing 1
Narni 1
Olomouc 1
Quezon City 1
Santarcangelo di Romagna 1
Shanghai 1
Terni 1
Tokyo 1
Toronto 1
Urmia 1
Vienna 1
Wuhan 1
Totale 1.238
Nome #
Interaction with damaged vessel wall in vivo in humans induces platelets to express CD40L resulting in endothelial activation. No effect of aspirin intake. 87
Abstract 15389: High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events 86
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 84
Dominant inheritance of a novel integrin beta3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families. 66
Effects of resveratrol and other wine polyphenols on vascular function: an update. 65
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 65
Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. 64
A novel nitric oxide-releasing statin derivative exerts and antiplatelet/antithrombotic activity and inhibits tissue factor expression. 62
Effect of substituted stilbenes on platelet function 61
A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry. 60
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 57
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 54
Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation. 53
Endothelial activation in patients with superficial vein thrombosis (SVT) of the lower limbs 52
Germline GATA2 variant disrupting endothelial eNOS cell function and angiogenesis can be restored by c-Jun/AP-1 upregulation 52
Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events. 51
Visualization of nitric oxide production by individual platelets during adhesion in flowing blood. 50
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 49
Increase of von Willebrand factor with aging in type 1 von Willebrand disease: Fact or fiction? 49
Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions 48
A novel nitric oxide-releasing statin derivative exerts an antiplatelet/antithrombotic activity and inhibits tissue factor expression. 46
Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage 46
Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs 44
HYPERGLYCEMIA-INDUCED PLATELET ACTIVATION IN TYPE 2 DIABETES MELLITUS IS RESISTANT TO ASPIRIN BUT NOT TO A NITRIC OXIDE-DONATING AGENT. 41
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry 41
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 38
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. 37
Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndrome. 35
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 32
Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: Meta-Analysis of 119 clinical trials involving 100 667 patients 32
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 30
A p.Arg127Gln variant in GPIbα LRR5 allosterically enhances affinity for VWF: a novel form of platelet-type VWD 28
Platelets release their lysosomal content in vivo in humans upon activation 25
Platelet dysfunction in platelet-type von Willebrand disease due to the constitutive triggering of the Lyn-PECAM1 inhibitory pathway 21
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 19
Usefulness of global tests of primary hemostasis in the initial screening of mild/moderate bleeding disorders for orienting towards von Willebrand disease or inherited platelet functions disorders 19
COVID-19 infection-associated platelet and neutrophil activation is blunted by previous anti-SARS-CoV-2 vaccination 17
Gestational diabetes mellitus is associated with in vivo platelet activation and platelet hyperreactivity 13
Totale 1.779
Categoria #
all - tutte 8.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.698


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020105 0 0 0 0 12 11 15 4 22 32 3 6
2020/2021212 3 9 7 12 66 9 28 2 23 13 16 24
2021/2022280 14 59 8 12 10 2 5 74 10 6 44 36
2022/2023573 35 133 9 74 43 50 0 8 202 2 14 3
2023/2024282 10 16 13 7 4 2 109 3 19 12 45 42
2024/2025169 11 51 35 29 43 0 0 0 0 0 0 0
Totale 1.779